Omalizumab treatment in adolescents with chronic spontaneous urticaria: Efficacy and safety
Omalizumab treatment in adolescents with chronic spontaneous urticaria: Efficacy and safety is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Omalizumab treatment in adolescents with chronic spontaneous urticaria: Efficacy and safety have?
Omalizumab treatment in adolescents with chronic spontaneous urticaria: Efficacy and safety has 16 citations in the OpenAlex counts ScholarIQ stores.
When was Omalizumab treatment in adolescents with chronic spontaneous urticaria: Efficacy and safety published?
Omalizumab treatment in adolescents with chronic spontaneous urticaria: Efficacy and safety has 2020 year in the ScholarIQ index.
What is the open-access status of Omalizumab treatment in adolescents with chronic spontaneous urticaria: Efficacy and safety?
Omalizumab treatment in adolescents with chronic spontaneous urticaria: Efficacy and safety has gold oa status in the ScholarIQ index.
What is the DOI of Omalizumab treatment in adolescents with chronic spontaneous urticaria: Efficacy and safety?
The DOI for Omalizumab treatment in adolescents with chronic spontaneous urticaria: Efficacy and safety is on the source record.
What is the PMID of Omalizumab treatment in adolescents with chronic spontaneous urticaria: Efficacy and safety?
The PMID for Omalizumab treatment in adolescents with chronic spontaneous urticaria: Efficacy and safety is on the source record.
What is the OpenAlex record for Omalizumab treatment in adolescents with chronic spontaneous urticaria: Efficacy and safety?
The OpenAlex for Omalizumab treatment in adolescents with chronic spontaneous urticaria: Efficacy and safety is on the source record.